Prasugrel Versus Ticagrelor in Patients With CYP2C19 Loss-of-function: a Validation Study

NCT03489863 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

14

Enrollment

OTHER

Sponsor class

Conditions

Coronary Artery Disease

Interventions

DRUG: Prasugrel
DRUG: Ticagrelor

Sponsor

University of Florida

Collaborators

[object Object]